RVL Pharmaceuticals Joins AmSpa as Platinum Vendor Affiliate

May 8, 2023
RVL Pharmaceuticals

RVL Pharmaceuticals has joined the American Med Spa Association (AmSpa) as a Platinum Vendor Affiliate.

RVL Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing eye care and medical aesthetics products. Its first approved product, Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%, provides the foundation of its commitment to improve patients’ lives. Upneeq is available through the UP+ program, which allows you to dispense Upneeq directly to your appropriate adult patients.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AMA Urges HHS to Withdraw Proposal Expanding Access to Certain Unapproved Peptides
    • Health Canada Warns Against Unauthorized Peptides After Bacteria Found in Seized Products
    • FDA Authorizes Clinical Trials Evaluating Lynch Regenerative Medicine’s rhPDGF-BB for Facial Skin Quality and Infraorbital Hollows
    • Hims & Hers Launches Peptides+ for Men
    • Alpha Aesthetics Partners Launches Clinical Education for Platform Practices